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There has been increasing use of in vitro cell culture models that more realistically replicate 
the three dimensional (3D) environment found in vivo. Multicellular tumour spheroids (MTS) 
using cell lines or patient-derived organoids have become an important in vitro drug 
development tool, where cells are grown in a 3D ‘sphere’ that exhibits many of the 
characteristics found in vivo. Significantly, MTS develop gradients in nutrients and oxygen, 
commonly found in tumours, that contribute to therapy resistance. While MTS show promise 
as a more realistic in vitro culture model, there is a massive need to improve imaging 
technologies for assessing biochemical characteristics and drug response in such models to 
maximize their translation into useful applications such as high throughput screening (HTS). 
In this study we investigate the potential for Raman spectroscopy to unveil biochemical 
information in MTS and have investigated how spheroid age influences drug response, 
shedding light on increased therapy resistance in developing tumours. The wealth of 
molecular level information delivered by Raman spectroscopy in a noninvasive manner, could 
aid translation of these 3D models into HTS applications.    
    
 
  
1. Introduction 
 
Drug and therapy resistance is a major issue in cancer therapeutics, with drug efficacy often 
failing to translate into the in vivo environment from in vitro studies.1, 2 One of the pitfalls of 
conventional in vitro models is that the cells exist in a two dimensional environment; growing 
on a flat surface that does not accurately reflect the three dimensional architecture of the 
body.3, 4 Therefore, studies of both underlying biochemistry and drug efficacy screening can 
often be misleading due to the simplified environment. Use of ex vivo and in vivo models can 
resolve many of these issues, however, access to such samples is limited and requires 
extensive ethical consideration before these can be used, particularly for in vivo studies. 
Therefore, while they provide a more realistic environment, it is difficult to meet the high 
throughput demands that in vitro models can provide.5 In recent years, attention has turned to 
3D in vitro models that involve growing cells in a three dimensional environment that more 
closely resembles that found in the body.6 Cells can be mixed with and grown in both natural 
and synthetic scaffolds such as collagen7 and peptide hydrogels8 respectively. One popular 3D 
culture method is the formation of multicellular tumour spheroids (MTS). In particular, these 
mimic the physiological characteristics of cancer tumours by developing gradients in 
characteristics such as oxygen concentration, nutrient concentration and pH, similar to those 
found as a cancer tumour grows in the body.4, 9 As a tumour grows, central regions become 
cut-off from the well-organised vasculature of the body that supplies oxygen and nutrients to 
cells. Despite cancer cells signaling for formation of new blood vessels10, the vessels tend to 
be disorganised and leaky, with no pressure differential to encourage flow, therefore failing to 
meet adequate oxygen and nutrient demands typical of normal cells.11, 12 Therefore, gradients 
develop, often leading to the formation of hypoxic core regions in bloodflow (and therefore 
oxygen) -deprived regions.13, 14 This hypoxic characteristic can confer resistance to many 
therapies.15, 16 While lack of blood vessels makes vascular drug delivery inefficient17, 
  
radiotherapy is also less effective because it relies on the presence of oxygen to form reactive 
oxygen species to destroy cancer cells. Therefore, MTS can provide an in vitro tumor model 
that can more accurately reflect in vivo cancer physiology and responses to therapy. 
 
While these 3D in vitro models address many of the biological problems associated with 
traditional 2D in vitro culture, there are limitations with regards to tools for their analysis.4, 18 
For example, techniques such as Western blot, polymerase chain reaction and electrophoresis 
allow detailed analysis of overall protein and DNA composition, but are destructive and 
involve lysing the 3D culture to extract biomolecules.19,20 Such spatially insensitive 
techniques are also time consuming, and new analytical methods are sought after.21 
Biomolecular imaging of intact cells within MTS is limited primarily by the absence of 
imaging technologies that allow sufficient depth penetration into a 3D structure. More recent 
advances have seen successful fluorescence imaging of intact MTS using light sheet 
fluorescence microscopy where the sample is illuminated by a sheet of light through each 
plane, followed by collection of emitted light perpendicular to this.22 Using light sheet 
fluorescence microscopy, photobleaching and photodamage are limited, 3D structures can be 
more rapidly imaged whilst still alive and MTS can be imaged over their full depth.  
Fluorescence imaging itself, however, has its own drawbacks - requiring incorporation of a 
fluorophore that could interfere with native intracellular biochemistry. In addition, each 
fluorophore only probes one specific biomolecule, and therefore the biochemical information 
that can be gained in this way is severely limited.  
 
Raman spectroscopy has been used previously for analysis of biological samples in vitro, ex 
vivo, and in vivo.23 It allows samples to be probed in a label-free and non-destructive manner, 
giving a high level of chemically specific, molecular level detail. To our knowledge, this 
technique has not previously been used to analyse therapy response in MTS but Raman24 and 
  
surface enhanced Raman spectroscopy14, 25, 26 have shown promise previously for measuring 
characteristics of MTS. Its advantageous characteristics have allowed a detailed biochemical 
analysis to be made without the need for external labels, providing a high level of spatially 
resolved biomolecular detail relating to drug-resistance in ageing spheroids. While this study 
uses fixation, paraffin embedding and sectioning of MTS, which is destructive of the live 
MTS sample, the analysis of the sectioned sample itself using Raman spectroscopy is non-
destructive, and each spheroid section can thus be analysed multiple times. There is also no 
application of external agents to the sample prior to fixation, such as fluorescence or 
colorimetric stains, which could alter the innate biochemistry of the sample. Ultimately the 
capabilities of Raman spectroscopy, investigated in this study, can be extended to analysis of 
intact live samples. Staurosporine is a protein kinase inhibitor and potent pro-apoptotic agent, 
with strong anti-cancer properties, and as such was selected as the therapeutic agent of choice 
to demonstrate the premise of this work.27 While MCF7 cells lack caspase-3, a key protein in 
the apoptotic process, it has been demonstrated that staurosporine still induced lethality to 
MCF7 cells in 2D culture.28 
 
 
 
2. Materials and Methods 
 
2.1. Cell culture MCF7 human breast cancer cells (gifted from Division of Pathology 
Laboratories, Western General Hospital, Edinburgh) were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 1% penicillin/streptomycin (10,000 units/ml) 
and 10% heat-inactivated fetal bovine serum (FBS). Cells were incubated at 37 °C and 5% 
CO2 in a humidified incubator.   
MTS were prepared using the hanging drop technique.29 MCF7 cell spheroids have previously 
been successfully grown using a hanging drop30 and other methods31, and the hanging drop 
  
technique has been optimised for MCF7 MTS through extensive work in our group.14, 25, 32 
Cells were grown in monolayer culture as normal. Cells were trypsinised, pelleted by 
centrifugation and resuspended in 0.5 ml of medium. 20 µl drops of cell suspension were 
pipetted onto the lid of a plastic Petri dish and approximately 5-10 ml of medium was added 
to the bottom of the dish. The lid containing hanging drops was placed on the Petri dish and 
MTS were grown in the drops over a period of 6, 12 or 15 days.  
 
2.2. Staurosporine treatment Medium was removed from hanging drops and replaced with 
20 µl of 10 µM staurosporine (STS) in DMEM, for 1 hour. 
 
2.3. Spheroid fixation Medium, either with or without STS, was removed from hanging 
drops and replaced with 20 µl 4% paraformaldehyde. After approximately 10 minutes, MTS 
were transferred to an Eppendorf and stored in 4% paraformaldehyde. 
 
2.4. Paraffin embedding and histology MTS were processed using standard histology 
procedures for paraffin embedding and sectioning at the Division of Pathology Laboratories, 
Western General Hospital, Edinburgh. Spheroids were sectioned (3 µm) onto calcium fluoride 
windows and dewaxed prior to Raman analysis. Adjacent sections were sectioned onto glass 
slides and stained with Hematoxylin and Eosin. 
 
2.5. Raman mapping Raman spectra were acquired on a Renishaw inVia Raman microscope 
equipped with a 532 nm Nd:YAG laser giving a maximum power of 500 mW, 1800 l/mm 
grating, and using a Leica 50×/NA 0.75 N PLAN EPI objective. Full MTS sections were 
mapped using a step size of 5 µm in x and y, 3 s acquisition time, 50% laser power and a 
spectral centre of 1300 cm−1. The high resolution section through the Day 15 MTS was 
  
mapped using a step size of 1 µm in x and y, 1 s acquisition time, 50% laser power and a 
spectral centre of 1300 cm−1. 
 
2.6. Raman data processing Pre-processing of all maps was performed using Renishaw Wire 
4.2 software. Cosmic rays were removed using the Width of Features algorithm (width 
parameter 3, height parameter 15) followed by smoothing using Savitsky-Golay smoothing 
(smooth window 9, polynomial order 3) and finally baseline subtraction.  
For full MTS section maps, spectra were then imported into MATLAB R2016a and processed 
using custom scripts (available on request). Remaining outlier spectra (due to cosmic rays 
and/or saturation) were removed using the threshold tool followed by selection of cell regions 
using the threshold tool, both based on total spectral intensity. Spectra were normalised 
between 0 and 1. A quality control step was applied to the spectral data set from each 
condition such that all spectra outwith one standard deviation of the mean were removed. This 
removed poor quality, noisy and outlier spectra and improved further analysis. For principal 
component analysis (PCA) the relevant data sets were combined in each case, followed by 
normalising between 0 and 1, and determination of the first derivative of each spectrum using 
13 smoothing points. PCA was then performed on the first derivative spectra and results were 
plotted. First derivative spectra were used to minimise contributions from non-specific 
baseline variations to the spectral peak variation derived from biological species. In addition, 
average spectra were plotted for comparison and scatter plots were generated plotting 
intensity at 963 cm−1 and intensity of 1012 cm−1.  For the Day 15 MTS map, the impoly 
function was used to separate central and outer regions of the MTS and comparison was then 
made between these regions using the same processing steps.  
For the high resolution map section, principal component analysis was performed in 
Renishaw Wire 4.2 software using minimum total variance explained (98%) and spectrum 
centering and normalisation with mean-centre.  
  
For statistical comparison of intensities at 963 cm−1 and 1012 cm−1, GraphPad Prism 7.03 was 
used to perform Mann-Whitney tests on the data. 
 
 
3. Results and Discussion  
 
In this study we explored the potential for Raman spectroscopy to be used for detailed 
analysis of MTS in order to assess important underlying biochemistry, that could be vital for 
consideration in cancer therapy. Raman analysis was carried out on fixed and sectioned 
spheroids where the sections provided a representative radial profile of MTS. Highly resolved 
Raman maps were obtained, with spatial resolution of 1 µm easily obtainable. The 
biochemical changes in ageing MTS were investigated in a label free manner using Raman 
spectroscopy, with MTS grown for 6, 12 and 15 days. Additionally, the apoptosis-inducing 
drug staurosporine (a protein kinase inhibitor) was used to determine sensitivity to drug as a 
function of spheroid age.  
 
MTS grown over 6, 12 and 15 days, both untreated and treated for 1 hour with 10 µM 
staurosporine were analysed using Raman spectroscopy. Raman mapping was performed on 
spheroid sections, with the aim to gain new insight into biochemistry of MTS using this label 
free and chemically specific vibrational technique. Following spectral processing, spectra 
extracted from maps for each condition were compared, and adjacent sections stained with 
haematoxylin and eosin (H&E) (Figure 1) provided a comparison with more routine 
biochemical analytical methodology. Spheroid shapes varied between conditions, which could 
partly be attributed to sample to sample variation and potential artefacts from fixation and 
sectioning procedures. It is noteworthy however that 6 day old MTS appeared to have more 
densely packed cells than 12 or 15 day old MTS, in keeping with areas of necrosis that 
develop in older MTS. The difference in shape before and after STS treatment was also more 
  
apparent for 6 day old MTS, and in particular the nuclear staining with hematoxylin appeared 
to indicate only a small necrotic region in the centre of untreated 6 day old MTS where nuclei 
were condensed and densely packed, but which became more pronounced in STS-treated 
MTS of the same age. The 15 day old MTS showed a much larger central necrotic region, 
indicated by the same nuclear pattern, with a less pronounced change in these characteristic 
necrotic regions in STS treated 15 day old MTS. While no specific molecular markers were 
used to distinguish proliferative, hypoxic and necrotic regions of MTS, H&E staining 
confirmed the establishment of a larger necrotic region in older MTS, and a less pronounced 
change in morphology both at the spheroid and cell level for older MTS.   
 
3.1. Investigating biochemical changes induced by STS treatment on MTS of different 
ages  
Principal component analysis (PCA) was used to compare the spectra between MTS of 
different ages and treatments (Figure 2). PCA is an unsupervised multivariate analysis 
technique that reduces the dimensionality of multivariate data into principal components 
(PCs) that sequentially describe the primary sources of variation in a data set such that PC1 
explains the largest source of variation, followed by PC2 and so on. For each time point, a 
plot of PC1 and PC2 revealed a separation between untreated and STS treated MTS. The 
discriminatory power of PCA to distinguish between untreated and STS treated MTS became 
less apparent as MTS age increased, with a distinct separation in PC2 for 6 day old MTS 
(Figure 2a), a less distinct separation in PC2 for 12 day old MTS (Figure 2b) and only a 
nominal separation in PC1 for 15 day old MTS (Figure 2c). Even in 6 day old MTS there was 
some overlap between non-treated and STS treated MTS, which is probably a result of 
variation in response to drug treatment over the area of the MTS such that central more 
necrotic regions, while perhaps not as developed as in the older MTS, show minimal response 
to treatment and thus overlap more with the untreated MTS. In order to reveal the particular 
  
spectral signals that resulted in these discriminations, PC loadings for the PCs causing the 
separations were investigated. For 6 day old MTS, PC2 (Figure 2d) loadings revealed the 
major sources of variation between STS treated and untreated MTS, with PC2 showing a very 
predominant contribution from a peak around 1012 cm−1. For 12 day old MTS, PC2 loadings 
(Figure 2e) revealed prominent signals at 1004 cm−1, 1295 cm−1, 1448 cm−1 and 963 cm−1 that 
distinguished untreated from STS treated MTS. Finally, for 15 day old MTS, the PC1 
loadings (Figure 2f) suggest major contribution from 1295 cm−1, 1004 cm−1, 1134 cm−1, 1063 
cm−1, 1439 cm−1 and 963 cm−1.  
 
While peaks at 1063 cm−1 , 1134 cm−1 ,1295 cm−1 and 1439 cm−1 probably arise from paraffin 
(despite dewaxing, see ESI Figure S1 for spectrum of paraffin), spectral features at 1004 cm−1, 
1295 cm−1, 1448 cm−1, 1134 cm−1 and 1063 cm−1 are common strong assignments found in 
biological Raman spectra assigned to phenylalanine, CH2 group twisting, CH2/CH3 group 
scissoring, C-C stretching and C-C stretching respectively.33, 34 However, the two peaks at 963 
cm−1 and 1012 cm−1 were identified to be prominent distinguishing signals between untreated 
and STS treated MTS. In order to compare peaks in this region more closely, average spectra 
for each MTS were plotted and compared (Figure 3). In particular focus was directed towards 
the region between 900 cm−1 and 1100 cm−1 containing the 963 cm−1 and 1012 cm−1 peaks. 
Additionally, in order to simplify comparison, individual spectra from the maps were plotted 
as scatter plots of intensity of these two peaks (Figure 4). These measures highlight the major 
sources of important spectral variation between MTS. The appearance of a peak at 1012 cm−1 
for STS treated compared to untreated 6 day old MTS was a major distinguishing feature, 
highlighted further by the distribution of points in Figure 4a. In comparison, STS treated 
compared to untreated 12 day old MTS was distinguished by a loss of signal at 963 cm−1. 
Finally, for 15 day old MTS, the changes in these peaks were indistinct, with the scatter plot 
  
in Figure 4c revealing only a small change in these signals with slightly higher intensity at 
1012 cm−1 for untreated MTS compared to STS treated MTS.   
 
These observations translate to Raman spectra exhibiting increasingly similar profiles for 
MTS before and after STS treatment as the MTS age increased. As MTS grow they are known 
to mimick tumour growth by developing gradients in pH, nutrients and oxygen concentration 
as central regions move further from the supply of these essential components. Eventually 
these central regions can become necrotic, with an intermediate region of non-proliferating 
quiescent cells. Similar to hypoxic tumours becoming increasingly resistant to therapy as they 
grow, MTS may develop increasing resistance as they age, again mimicking closely the 
characteristics of cancer in vivo. Previous studies have demonstrated a relationship between 
increased levels of hypoxia and necrosis in MTS as they grow over longer time periods and 
resistance to chemotherapeutic agents including 5-fluorouracil, cisplatin and staurosporine.13, 
35 Therefore, the observation via Raman spectroscopy that MTS became increasingly resistant 
to STS treatment with age is understandable in terms of the underlying biology of the MTS 
and supports evidence from previous investigations. This adds to previous research outlining 
the importance of considering spheroid age, and therefore biochemical characteristics, when 
using MTS in screening assays to mimic the in vivo environment – e.g. Däster et al.13 showed 
that older MTS with hypoxic and necrotic regions had gene expression profiles closer to those 
observed in vivo.  
 
3.2. Investigating biochemical changes as a factor of MTS age in untreated and STS 
treated MTS 
In addition to comparing treated to untreated MTS, all untreated MTS and all STS treated 
MTS were compared on the basis of their age (Figure 5). A PC plot of PC1 and PC2 (Figure 
5a) revealed a slight discrimination on PC1 and PC2 with MTS ages for untreated MTS. After 
  
STS treatment, discrimination between MTS of different ages became more apparent, 
suggesting that MTS response to STS varied with age. A plot of PC2 and PC3 revealed a 
distinct separation between STS treated MTS of different ages (Figure 5b). Analysis of 
spectra revealed an increase in signal at 963 cm−1 with spheroid age (Figure 5c), while for 
STS treated MTS only 15 day old MTS had a strong signal at 963 cm−1, with 6 day old MTS 
having a distinguishing peak at 1012 cm−1 (Figure 5d). Again scatter plots of the signal 
intensity at 963 cm−1 and 1012 cm−1 clarified these trends, with slight distinction on the basis 
of 963 cm−1 intensity for untreated MTS (Figure 5e), and clear separation of all three STS 
treated MTS (Figure 5f).  
 
In terms of molecular changes in the ageing MTS identified using Raman spectroscopy, the 
peaks observed at 963 cm−1 and 1012 cm−1 probably originate from cellular DNA. An 
extensive study into Raman spectroscopy of various DNA bases and changes in response to 
radiation damage observed changes to peaks in these regions as a result of radiation damage 
to DNA bases, similar to those observed in this study.36 A peak at 1012 cm−1 is assigned to a 
furanose vibration and we propose that the appearance of this peaks can be correlated with 
cellular DNA damage. Ruiz-Chica et al.37 also associated a peak at 1012 cm−1 with 
deoxyribose ring stretching. This peak is not commonly observed in Raman spectra of healthy 
cells and therefore it is possible that its presence reports on structural changes to cellular DNA, 
including age and drug induced damage to cellular DNA as a result of apoptosis or necrosis. 
The peak at 963 cm−1 could also be an indicator of DNA damage and suggests a different 
mode of DNA damage as MTS age. However, this peak also matches that assigned to calcium 
hydroxyapatite and it is possible that it indicates the formation of microcalcifications as the 
MTS age.38 Analysis of H&E stained sections indicates some inclusions that could be 
microcalcifications but they present a less clear distinction between MTS of different ages – 
further work is required to definitively assign this peak. 
  
 
3.3. Investigating zonation dependent intra-MTS biochemical variations 
In order to investigate these molecular changes further, the 15 day old MTS, which visually 
showed distinct zonation indicating a necrotic core (central region) surrounded by outer 
proliferating cells (outer region), was analysed in detail (Figure 1). Central and outer regions 
were separated based on visual inspection and compared using the same procedures used for 
previous analysis between conditions (Figure 6). PCA revealed a spectral separation on PC4, 
which was explained by the two peaks already indicated as the major sources of variation – 
1012 cm−1 and 963 cm−1. Combined with analysis of the average spectra in this region and 
scatter plots of intensity of these peaks, it was clear that central regions manifested a presence 
of the peak at 1012 cm−1, and while the 963 cm−1 peak was present in both regions, it was 
more predominant in the outer region. Therefore, in addition to distinguishing different MTS, 
these spectral signatures showed important variation within individual MTS. It is important to 
relate this back to observations made on the H&E stained MTS sections (Figure 1), where the 
central region of the 15 day old MTS was most obviously necrotic, with condensed, densely 
packed nuclear regions, similar in pattern to regions appearing in the STS treated 6 day old 
MTS. This further supports the association of the peak at 1012 cm−1 with DNA and DNA 
damage. There is also inconclusive staining observed in the outer region of the 15 day old 
MTS, where darker stained regions not typical in shape to nuclei, could indicate foci of 
microcalcification.  
 
The only other section which had a visibly distinguishable necrotic region was the 6 day old 
MTS. In this case there was no obvious separation between central and outer regions using 
PCA (Figure S2), however this could be expected as these much younger MTS were unlikely 
to have the same extent of necrosis in their central regions as the older 15 day old MTS. A 
comparison of average spectra revealed a slightly higher intensity at 1012 cm−1 for the central 
  
region, consistent with observations in 15 day old MTS but most likely at the very initial 
stages of developing DNA damage associated with necrosis, making the distinction between 
regions must less clear than for 6 day old MTS. Comparing necrotic central regions of 6 and 
15 day old MTS revealed a clear separation using PCA (Figure S3) again characterised 
predominantly by changes in the peaks at 963 cm−1 and 1012 cm−1.  
 
Finally, to explore this intra-MTS change further, a region of the 15 day old untreated MTS 
was mapped with higher resolution (1 µm in the x and y directions) in order to investigate a 
cross sectional profile through the MTS. PCA was then used to identify the key spectral 
signatures that varied within the high resolution map of the 15 day old MTS (Figure 7). As 
expected, PC1 identified a general cellular Raman signal that distinguished cellular from non-
cellular regions (Figure 7a-c). Interestingly, PC3 identified a component that had greatest 
abundance in the outer ring of the 15 day old MTS (Figure 7d-f), while PC4 identified a 
component that had greatest abundance in the inner necrotic core of the 15 day old MTS 
(Figure 7g-i). Upon investigating the loadings on PC3 and PC4, and representative spectra 
from regions with high abundance of PC3 and PC4, the outer region appeared to have a strong 
contribution from the peak at 963 cm−1 (Figure 7e-f), while the inner region had a strong 
contribution from the peak at 1012 cm−1 (Figure 7h-i). This is consistent with the previous 
hypothesis that the peak at 1012 cm−1 was characteristic of a marker of necrosis as a result of 
DNA damage.  
 
3.4. A new analytical tool for drug screening 
This study has demonstrated the potential for Raman spectroscopy for analysis of MTS in a 
non-invasive and non-destructive manner, and has revealed some key changes in Raman 
spectral profile both as spheroids age and in response to drug treatment – primarily 
identifying changes in signals at 963 cm−1 and 1012 cm−1 to be responsive to ageing and drug 
  
treatment. For such an analytical tool to be useful for drug screening on MTS, a method for 
determining whether a particular drug induced a change in MTS biochemistry upon treatment 
is necessary. In the simplest manner, the intensity at particular key wavenumbers can be 
extracted for all points in each MTS dataset and compared. Figure 8 shows box and whisker 
plots for the distribution of values for both the 963 cm−1 and 1012 cm−1 intensities for MTS 
under each condition. Mann-Whitney tests were used to compare untreated and STS treated 
MTS for each intensity and revealed whether there was a statistically significant difference 
upon drug treatment. Therefore, this could be used as a statistically valid indicator as to 
whether to pursue a particular drug treatment further. Results are in line with previous 
observations, revealing both intensities to change in a statistically significant manner for 6 
and 12 day old MTS and a statistically significant difference for the intensity at 1012 cm−1 for 
15 day old MTS but no significant difference for the intensity at 963 cm−1. While there was a 
statistically significant difference for the intensity at 1012 cm−1 for 15 day old MTS, the 
median value difference between untreated and treated MTS was low, a value that could act 
as a further indicator of the efficacy of a particular drug.   
 
4. Conclusion  
 
This study reports for the first time, Raman spectroscopic analysis of therapy response in 
multicellular tumour spheroids. While the 3D nature of MTS more closely mimics the in vivo 
tumour environment, analytical techniques for detailed and accurate analysis of MTS and 
spatially resolved changes in their biochemistry are limited. Here we explored the use of 
Raman spectroscopy explored as a label free method to allow detailed molecular level 
analysis of MTS in attempt to reveal important biochemical changes in MTS as they age and 
in response to drug treatment. Principal component analysis combined with direct analysis of 
spectra revealed key spectral changes at 963 cm−1 and 1012 cm−1. Raman analysis could then 
  
be simplified to consider scatter plots of the intensity of these two peaks plotted against one 
another. The appearance of a peak at 1012 cm−1 was probably indicative of DNA damage 
after induction of necrosis in 6 day old MTS treated with STS and as a result of necrotic core 
formation in 15 day old MTS. As the spheroids aged, the signal at 963 cm−1 increased and we 
suggest that this is either due to the formation of microcalcifications or accumulated DNA 
damage. In addition, intra-MTS analysis of 15 day old MTS showed spatial variations in these 
spectral signals with the necrotic core region correlated strongly with the presence of a peak at 
1012 cm−1 and the outer regions containing more contribution from the 963 cm−1 signal. 
Raman spectroscopy is therefore a powerful analytical tool for increasing understanding 
biochemical changes in ageing MTS (both inter- and intra-MTS) in addition to drug induced 
molecular changes in a label free manner with potential for high levels of spatial resolution. 
This information could be used to both reveal a more detailed understanding of spheroid 
biology, and provide Raman spectral markers to monitor in high throughput screening 
applications, potentially using statistical analysis to compare key peak intensities. 
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Additional supporting information may be found in the online version of this article at the 
publisher’s website. 
Figure S1: Raman spectrum of paraffin 
Figure S2: Comparison of central and outer regions of 6 day old MTS 
Figure S3: Comparison of central regions of 6 and 15 day old MTS 
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Figure 1 Haematoxylin and Eosin stained multicellular tumour spheroids (left) and total 
Raman intensity of spheroid regions extracted for analysis from Raman maps (right) for 
untreated (a) and STS treated (b) 6 day old spheroids; untreated (c) and STS treated (d) 12 day 
old spheroids; and untreated (e) and STS treated (f) 15 day old spheroids. Spheroid sections 
were mapped on a Raman microscope using 5 µm steps in the x and y directions, 3 s 
acquisition time, 50% laser power and a spectral centre of 1300 cm−1 and each unit in the x 
and y direction represents 5 µm.  
  
 
Figure 2. Principal component analysis was used to compare spectra from multicellular 
tumour spheroid sections mapped on a Raman microscope using 5 µm steps in the x and y 
directions, 3 s acquisition time, 50% laser power at 532 nm and a spectral centre of 1300 cm−1. 
Spectra extracted from cell regions were compared for 6 day old spheroids with and without 
staurosporine (STS) treatment (a); 12 day spheroids with and without STS treatment (b); and 
15 day old spheroids with and without STS treatment (c). The principal component loadings 
corresponding to the principal component (PC) over which conditions separated in each case 
– PC2 (d), PC2 (e) and PC1 (f) respectively – are given. 
 
 
 
 
 
 
 
 
  
 
Figure 3. Average spectra from multicellular tumour spheroid sections mapped on a Raman 
microscope using 5 µm steps in the x and y directions, 3 s acquisition time, 50% laser power 
at 532 nm and a spectral centre of 1300 cm−1. Spectra extracted from cell regions were 
compared for 6 day old spheroids with and without staurosporine (STS) treatment (a,b); 12 
day spheroids with and without STS treatment (c,d); and 15 day old spheroids with and 
without STS treatment (e,f). Difference spectra of the mean STS treated condition subtracted 
from the mean untreated condition for each spheroid age are given (g,h) to emphasise the 
regions of maximal change. Difference spectra are offset by 0.5 for clarity and peaks at 963 
cm−1 and 1012 cm−1 are highlighted in yellow. 
 
Figure 4. Scatter plots of the intensity of the peak at 1012 cm−1 and intensity of the peak at 
963 cm−1 from spectra from multicellular tumour spheroid sections mapped on a Raman 
microscope using 5 µm steps in the x and y directions, 3 s acquisition time, 50% laser power 
at 532 nm and a spectral centre of 1300 cm−1. Plots are compared for 6 day old spheroids with 
and without staurosporine (STS) treatment (a); 12 day spheroids with and without STS 
treatment (b); and 15 day old spheroids with and without STS treatment (c). 
  
 
Figure 5. Principal component analysis (PCA) was used to compare spectra from 
multicellular tumour spheroid sections mapped on a Raman microscope using 5 µm steps in 
the x and y directions, 3 s acquisition time, 50% laser power at 532 nm and a spectral centre 
of 1300 cm−1. Spectra extracted from cell regions were compared using PCA for untreated 6, 
12 and 15 day old spheroids (a); and for STS treated 6, 12 and 15 day old spheroids (b). 
Average spectra for untreated (c) and STS treated (d) 6, 12 and 15 day old spheroids; and 
scatter plots of the intensity of the peak at 1012 cm−1 and intensity of the peak at 963 cm−1 for 
untreated (e) and STS treated (f) 6, 12 and 15 day old spheroids are also compared. 
  
 
Figure 6. Extracted Raman spectra from a 15 day old multicellular tumour spheroid section 
mapped on a Raman microscope using 5 µm steps in the x and y directions, 3 s acquisition 
time, 50% laser power at 532 nm and a spectral centre of 1300 cm−1 were separated into 
central (a) and outer (b) regions (colour scale corresponds to total spectral intensity and 
spatial coordinates to µm). Spectra extracted from central and outer regions were compared 
using PCA (c), where they separated on principal component 4 (d). Average spectra of the 
regions compared (e) and scatter plots of the intensity of the peak at 1012 cm−1 and intensity 
of the peak at 963 cm−1 (f) are also compared. 
  
 
Figure 7. A high resolution cross section through a 15 day old multicellular tumour spheroid 
was mapped on a Raman microscope using 1 µm steps in the x and y directions, 1 s 
acquisition time, 50% laser power at 532 nm and a spectral centre of 1300 cm−1. Principal 
component analysis (PCA) on this map revealed principal component (PC) 1 to correlate with 
cell regions (a), where the loadings on PC1 (b) correlated with common cell Raman signals 
and a representative example spectrum from the point indicated with the white cross in (a) is 
given (c). PC3 showed higher intensity in the outer regions of the spheroid (d), where the 
loadings on PC3 (e) had primary contribution from the signal and 963 cm−1 and a 
representative example spectrum of high intensity from the point indicated with the white 
cross in (d) is given (f). PC4 showed higher intensity in the central regions of the spheroid (g), 
where the loadings on PC4 (h) had primary contribution from the signal and 1012 cm−1 and a 
representative example spectrum of high intensity from the point indicated with the white 
cross in (g) is given (i). 
 
 
  
 
Figure 8. Box and whiskers plots (minimum, 1st quartile, median, 3rd quartile, maximum) of 
the distribution of intensities at 963 cm−1 (a,c,e) and 1012 cm−1 (a,c,e) for 6 (a,b), 12 (c,d) and 
15 (e,f) day old MTS both untreated and treated with treated with STS. The difference 
between the untreated and STS treated median values is given in each case and Mann-
Whitney tests were performed in each case: **** = p<0.0001; ns = not significant.  
